Mitocon’s Mitochondrial Diseases Conference

In October, Abliva will attend the Italian patient organization Mitocon’s annual Mitochondrial Diseases Conference in Rome, Italy.

On October 8, Abliva’s Chief Medical Officer Magnus Hansson will give the talk: An adaptive, clinical Phase 2/3 study evaluating the efficacy of KL1333 in adult primary mitochondrial disease patients in Session 5: Challenges and pitfalls in clinical trials design – presentations and round table discussion.